Anergy and cytokine-mediated suppression as distinct superantigen-induced tolerance mechanisms in vivo

C Miller, JA Ragheb, RH Schwartz - The Journal of experimental …, 1999 - rupress.org
C Miller, JA Ragheb, RH Schwartz
The Journal of experimental medicine, 1999rupress.org
Recombinant-activating gene 2 (RAG-2−/−) T cell receptor–transgenic mice repeatedly
injected with the superantigen staphylococcal enterotoxin A entered a tolerant state in which
splenic CD4+ T cells produced little interleukin (IL)-2, interferon γ, or IL-4. This state resulted
from a combination of both clonal anergy and cytokine-mediated immunosuppression. The
anergy persisted for at least 3 wk and could be distinguished from the suppression by a
decrease in IL-2 production per cell, a block in the activation of early response kinases, and …
Recombinant-activating gene 2 (RAG-2−/−) T cell receptor–transgenic mice repeatedly injected with the superantigen staphylococcal enterotoxin A entered a tolerant state in which splenic CD4+ T cells produced little interleukin (IL)-2, interferon γ, or IL-4. This state resulted from a combination of both clonal anergy and cytokine-mediated immunosuppression. The anergy persisted for at least 3 wk and could be distinguished from the suppression by a decrease in IL-2 production per cell, a block in the activation of early response kinases, and a failure to be reversed with anti–transforming growth factor (TGF)-β. Full suppression lasted for only 1 wk and involved both IL-10 and TGF-β, but required additional unknown molecules for optimal effect. These experiments show that complex in vivo interactions of multiple peripheral tolerance mechanisms can now be dissected at both the cellular and molecular levels.
rupress.org